In group I, nine cases (64%) suffered from CHF and dyspnea; they were treated with oral antifailure medications (diuretics, angiotensin-converting-enzyme inhibitors (ACEIs) and/or digoxin). The gene discussed is ACE; the disease is congestive heart failure.